Literature DB >> 19923339

Biomarkers in IBS: when will they replace symptoms for diagnosis and management?

Giovanni Barbara1, Vincenzo Stanghellini.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19923339     DOI： 10.1136/gut.2008.169672

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  14 in total

1.  IBS: biomarkers for IBS: ready for prime time?

Authors:  Giovanni Barbara
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

2.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

3.  Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.

Authors:  Hirotada Akiho; Eikichi Ihara; Kazuhiko Nakamura
Journal:  World J Gastrointest Pathophysiol       Date:  2010-08-15

Review 4.  Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome.

Authors:  Giovanni Barbara; Cesare Cremon; Roberto De Giorgio; Giovanni Dothel; Lisa Zecchi; Lara Bellacosa; Giovanni Carini; Vincenzo Stanghellini; Roberto Corinaldesi
Journal:  Curr Gastroenterol Rep       Date:  2011-08

Review 5.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

6.  Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 7.  Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders.

Authors:  M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  2015-08-11       Impact factor: 8.171

Review 8.  IBS and the role of otilonium bromide.

Authors:  Guy Boeckxstaens; Enrico S Corazziari; Fermín Mearin; Jan Tack
Journal:  Int J Colorectal Dis       Date:  2012-11-22       Impact factor: 2.571

9.  The immune system in irritable bowel syndrome.

Authors:  Giovanni Barbara; Cesare Cremon; Giovanni Carini; Lara Bellacosa; Lisa Zecchi; Roberto De Giorgio; Roberto Corinaldesi; Vincenzo Stanghellini
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

Review 10.  Visceral pain: the ins and outs, the ups and downs.

Authors:  Shafaq Sikandar; Anthony H Dickenson
Journal:  Curr Opin Support Palliat Care       Date:  2012-03       Impact factor: 2.302
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.